APOE varepsilon4 carriership determines a faster plasma p-tau217 progression in Abeta-positive individuals. Woo MS, Macedo AC, Hosseini SA, Therriault J, et al. Alzheimers Dement 2025;21:e71048.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Woo MS, Macedo AC, Hosseini SA, Therriault J, et al. APOE varepsilon4 carriership determines a faster plasma p-tau217 progression in Abeta-positive individuals. Alzheimers Dement 2025;21:e71048.
PMID: 41451854